Influenza and cardiovascular disease: Does swine-origin, 2009 H1N1 flu virus represent a risk factor, an acute trigger, or both?

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 1, 2010, Pages 49-58

  Lippi, Giuseppe ^a   Franchini, Massimo ^a   Favaloro, Emmanuel J ^b  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

2009 H1N1; Cardiovascular disease; Flue; Influenza; Myocardial infarction

Indexed keywords

LIPOPROTEIN;

ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENDOTHELIAL DYSFUNCTION; EPIDEMIC; HEART MUSCLE ISCHEMIA; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; LIPOPROTEIN METABOLISM; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

AGED; ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MIDDLE AGED; ORTHOMYXOVIRIDAE INFECTIONS; PRECIPITATING FACTORS; SWINE; VACCINATION;

EID: 77951084750     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1248724     Document Type: Review

References (77)

1. Yen H L., Webster R G. Pandemic influenza as a current threat. Curr Top Microbiol Immunol 2009 333 3-24
2. Gatherer D. The 2009 H1N1 influenza outbreak in its historical context. J Clin Virol 2009 45 (3) 174-178
3. Peiris J S., Poon L L., Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 2009 45 (3) 169-173
4. Dawood F S., Jain S, Finelli L et al, Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009 360 (25) 2605-2615
5. Brockwell-Staats C, Webster R G., Webby R J. Diversity of Influenza Viruses in Swine and the Emergence of a Novel Human Pandemic Influenza A (H1N1). Influenza Other Respi Viruses 2009 3 207-213
6. Kuiken T, Taubenberger J K. Pathology of human influenza revisited. Vaccine 2008 26 (Suppl 4) D59-D66
7. Schnitzler S U., Schnitzler P. An update on swine-origin influenza virus A/H1N1: a review. Virus Genes 2009 October 7 (Epub ahead of print)
8. Madsen W. New swine flu feared to be weaponized strain. Online Journal, April 27, 2009. Available at: http://onlinejournal.com/artman/publish/article- 4631.shtml Accessed November 6, 2009
9. Hauge S H., Dudman S G., Borgen K et al. Disease caused by the new influenza A(H1N1) virus [in Norwegian]. Tidsskr Nor Laegeforen 2009 129 (17) 1736-1739
10. Scalera N M., Mossad S B. The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus. Postgrad Med 2009 121 (5) 43-47
11. Centers for Disease Control and Prevention. 2009 H1N1 flu (swine flu) and you. Available at: http://www.cdc.gov/H1N1flu/qa.htm Accessed November 6, 2009
12. U.S. Department of Health & Human Services. Heart disease and the flu. Available at: http://www.flu.gov/individualfamily/healthconditions/ heartdisease/index.html Accessed November 6, 2009
13. Gurevich V S. Influenza, autoimmunity and atherogenesis. Autoimmun Rev 2005 4 (2) 101-105
14. Bourne G, Wedgwood J. Heart-disease and influenza. Lancet 1959 1 (7085) 1226-1228
15. Bainton D, Jones G R., Hole D. Influenza and ischaemic heart diseasea possible trigger for acute myocardial infarction? Int J Epidemiol 1978 7 (3) 231-239
16. Pesonen E, Siitonen O. Acute myocardial infarction precipitated by infectious disease. Am Heart J 1981 101 (4) 512-513
17. Spodick D H., Flessas A P., Johnson M M. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984 53 (4) 481-482
18. Vüllers R, Bültmann B, Fischer H, Haferkamp O. Influenza A virus infection, a precipitating factor for the major heart attack (authors transl) [in German]. MMW Munch Med Wochenschr 1980 122 (41) 1415-1417 (Pubitemid 10004867)
19. Tillett H E., Smith J W., Gooch C D. Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol 1983 12 (3) 344-352
20. Thompson W W., Shay D K., Weintraub E et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003 289 (2) 179-186 (Pubitemid 36068705)
21. Thompson W W., Shay D K., Weintraub E et al. Influenza-associated hospitalizations in the United States. JAMA 2004 292 (11) 1333-1340 (Pubitemid 39223224)
22. Bondarenko S S., Tumanov F A. The incidence of exacerbations in chronic diseases in patients hospitalized with influenza and para-influenza [in Russian]. Ter Arkh 1990 62 (11) 39-42
23. Bondarenko S S., Tumanov F A. The effect of influenza and para-influenza on the course of ischemic heart disease [in Russian]. Ter Arkh 1992 64 (3) 81-83
24. Clayton T C., Thompson M, Meade T W. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J 2008 29 (1) 96-103
25. Guan X R., Li X, Xin X M. et al. Influenza virus infection and risk of acute myocardial infarction. Inflammation 2008 31 (4) 266-272
26. Warren-Gash C, Smeeth L, Hayward A C. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009 9 (10) 601-610
27. Azambuja M I. Connections: can the 20th century coronary heart disease epidemic reveal something about the 1918 influenza lethality? Braz J Med Biol Res 2008 41 (1) 1-4
28. Paoletti R, Gotto A M. Jr, Hajjar D P. Inflammation in atherosclerosis and implications for therapy. Circulation 2004 109 (23, suppl 1) III20-III26
29. Mangge H, Hubmann H, Pilz S, Schauenstein K, Renner W, Mrz W. Beyond cholesterolinflammatory cytokines, the key mediators in atherosclerosis. Clin Chem Lab Med 2004 42 (5) 467-474 (Pubitemid 38779746)
30. Kher N, Marsh J D. Pathobiology of atherosclerosisa brief review. Semin Thromb Hemost 2004 30 (6) 665-672
31. Gattone M, Iacoviello L, Colombo M et al. Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age. Am Heart J 2001 142 (4) 633-640 (Pubitemid 32900489)
32. Pleskov V M., Bannikov A I., Gurevich V S., Pleskova IuV. Influenza viruses and atherosclerosis: the role of atherosclerotic plaques in prolonging the persistent form of influenza infection [in Russian]. Vestn Ross Akad Med Nauk 2003 4 (4) 10-13
33. Gurevich V S., Pleskov V M., Levaia M V., Bannikov A I., Mitrofanova L B., Urazgildeeva S A. Influenza virus infection in progressing atherosclerosis [in Russian]. Kardiologiia 2002 42 (7) 21-24
34. Madjid M, Naghavi M, Litovsky S, Casscells S W. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation 2003 108 (22) 2730-2736 (Pubitemid 37498972)
35. Pleskov V M., Bannikov A I., Zatsev IuV. The receptor-mediated endocytosis of influenza viruses and low-density lipoproteins by tissue cells [in Russian]. Vopr Virusol 1994 39 (3) 121-125
36. Marchesi S, Lupattelli G, Lombardini R et al. Acute inflammatory state during influenza infection and endothelial function. Atherosclerosis 2005 178 (2) 345-350 (Pubitemid 40193450)
37. Goswami B, Tayal D, Gupta N, Mallika V. Paraoxonase: a multifaceted biomolecule. Clin Chim Acta 2009 410 (12) 1-12
38. James R W. A long and winding road: defining the biological role and clinical importance of paraoxonases. Clin Chem Lab Med 2006 44 (9) 1052-1059
39. Van Lenten B J., Wagner A C., Nayak D P., Hama S, Navab M, Fogelman A M. High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection. Circulation 2001 103 (18) 2283-2288 (Pubitemid 32433719)
40. Van Lenten B J., Wagner A C., Anantharamaiah G M. et al. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide. Circulation 2002 106 (9) 1127-1132
41. Naghavi M, Wyde P, Litovsky S et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 2003 107 (5) 762-768 (Pubitemid 36222607)
42. Keller T T., van der Meer J J., Teeling P et al. Selective expansion of influenza A virus-specific T cells in symptomatic human carotid artery atherosclerotic plaques. Stroke 2008 39 (1) 174-179
43. Barinov V G., Bogomolov B P., Deviatkin A V., Shvedova L P. Hemostatic changes in various clinical courses of influenza [in Russian]. Klin Med (Mosk) 1989 67 (6) 104-107
44. Bogomolov B P., Barinov V G., Deviatkin A V. et al. Hemostasis in influenza and acute respiratory viral infections in the middle-aged and elderly [in Russian]. Ter Arkh 1990 62 (7) 98-102
45. Visseren F L., Bouwman J J., Bouter K P., Diepersloot R J., de Groot P H., Erkelens D W. Procoagulant activity of endothelial cells after infection with respiratory viruses. Thromb Haemost 2000 84 (2) 319-324
46. Bouwman J J., Visseren F L., Bosch M C., Bouter K P., Diepersloot R J. Procoagulant and inflammatory response of virus-infected monocytes. Eur J Clin Invest 2002 32 (10) 759-766
47. Anisimova IuN, Trushnikova G V. Infectious-toxic shock and disseminated intravascular coagulation in a pregnant woman with influenza. Arkh Patol 1994 56 79-82
48. Terada H, Baldini M, Ebbe S, Madoff M A. Interaction of influenza virus with blood platelets. Blood 1966 28 (2) 213-228
49. Terada H. Studies on platelets and interaction with particular reference to the interaction of influenza virus with blood platelets [in Japanese]. Nippon Ketsueki Gakkai Zasshi 1969 32 (1) 45-51
50. Chernesky M A., Larke R P., Turpie A G. Interaction between viruses and platelets: requirement of haemolytic activity for platelet aggregation induced by paramyxoviruses. J Gen Virol 1973 21 (2) 205-213
51. Bogomolov B P., Deviatkin A V., Efimov L L., Mitiushina S A. Microcirculation, hemostasis, and hemorheology in influenza and acute respiratory viral infections in patients with hypertension [in Russian]. Ter Arkh 2001 73 (11) 7-11
52. Bogomolov B P., Deviatkin A V. Microcirculation and hemostasis in influenza and acute viral respiratory infections complicated with pneumonia [in Russian]. Ter Arkh 2002 74 (3) 44-48
53. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000 102 (25) 3039-3045
54. Nichol K L., Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003 348 (14) 1322-1332 (Pubitemid 36384099)
55. Gurfinkel E P., de la Fuente R L., Mendiz O, Mautner B. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 2002 105 (18) 2143-2147 (Pubitemid 34517156)
56. Gurfinkel E P., de la Fuente R L. Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry. Tex Heart Inst J 2004 31 (1) 28-32
57. van der Sande M A., van Asten L, Straus S M., Schim van der Loeff M F., Wallinga J, Conyn-van Spaendonck M A. Sudden deaths following influenza vaccination: can this be expected? Vaccine 2008 26 (3) 379-382
58. Davis M M., Taubert K, Benin A L. et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. J Am Coll Cardiol 2006 48 (7) 1498-1502 (Pubitemid 44436830)
59. Ciszewski A, Bilinska Z T., Brydak L B. et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J 2008 29 (11) 1350-1358 (Pubitemid 351806477)
60. Warren-Gash C, Smeeth L, Hayward A C. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009 9 (10) 601-610
61. Lavalle P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002 33 (2) 513-518 (Pubitemid 34123398)
62. Grau A J., Fischer B, Barth C, Ling P, Lichy C, Buggle F. Influenza vaccination is associated with a reduced risk of stroke. Stroke 2005 36 (7) 1501-1506 (Pubitemid 40967520)
63. Heffelfinger J D., Heckbert S R., Psaty B M. et al. Influenza vaccination and risk of incident myocardial infarction. Hum Vaccin 2006 2 (4) 161-166 (Pubitemid 44422482)
64. Jackson L A., Yu O, Heckbert S R. et al, Vaccine Safety Datalink Study Group. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 2002 156 (7) 634-640
65. Jackson L A., Nelson J C., Benson P et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 2006 35 (2) 345-352
66. Madjid M, Lillibridge S, Mirhaji P, Casscells W. Influenza as a bioweapon. J R Soc Med 2003 96 (7) 345-346 (Pubitemid 36842998)
67. Doshi P. Trends in recorded influenza mortality: United States, 19002004. Am J Public Health 2008 98 (5) 939-945 (Pubitemid 351671589)
68. Lippi G, Plebani M. Rapid diagnosis of swine-origin influenza A (H1N1) virus (S-OIV): useful or hype? Clin Chem Lab Med 2010 48 (1) 1-5
69. Flucount.org. Swine flu infection data. Available at: http://www.flucount.org/ Accessed November 6, 2009
70. Petrosillo N, Di Bella S, Drapeau C M., Grilli E. The novel influenza A (H1N1) virus pandemic: an update. Ann Thorac Med 2009 4 (4) 163-172
71. Domnguez-Cherit G, Lapinsky S E., Macias A E. et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009 302 (17) 1880-1887
72. Madjid M, Aboshady I, Awan I, Litovsky S, Casscells S W. Influenza and cardiovascular disease: is there a causal relationship? Tex Heart Inst J 2004 31 (1) 4-13 (Pubitemid 38366809)
73. Donaldson G C., Keatinge W R. Excess winter mortality: influenza or cold stress? Observational study. BMJ 2002 324 (7329) 89-90
74. Keatinge W R. Winter mortality and its causes. Int J Circumpolar Health 2002 61 (4) 292-299
75. Lippi G, Franchini M, Montagnana M, Filippozzi L, Favaloro E J., Guidi G C. Relationship between 24-h air pollution, emergency department admission and diagnosis of acute coronary syndrome. J Thromb Thrombolysis 2009 June 25 (Epub ahead of print)
76. Louie J K., Acosta M, Winter K et al, for the California Pandemic (H1N1) Working Group. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009 302 (17) 1896-1902
77. Madjid M, Casscells S W. Of birds and men: cardiologists role in influenza pandemics. Lancet 2004 364 (9442) 1309